Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest GlaxoSmithKline Stories

2013-11-15 08:26:58

CARLSBAD, Calif., Nov. 15, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $5 million milestone payment from GlaxoSmithKline (NYSE: GSK) related to the designation of ISIS-GSK4(Rx )as a development candidate. ISIS-GSK4(Rx) is an antisense drug designed to treat an undisclosed ocular disease. (Logo: http://photos.prnewswire.com/prnh/20130807/LA60006LOGO) "Our collaboration with GlaxoSmithKline has been very productive resulting...

2013-11-12 23:33:33

On September 26, a federal judge ordered to remand a Paxil birth defects lawsuit to Pennsylvania State Court. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Paxil side effects. San Diego, CA (PRWEB) November 12, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert...

2013-11-11 16:24:37

- Data Include Contrave Information on Weight Loss, Caloric Intake and Body Composition, and Eating Disorder Improvement - SAN DIEGO and DEERFIELD, Ill., Nov. 11, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceuticals U.S.A., Inc. (Takeda), today announced multiple Contrave® (naltrexone sustained release (SR)/bupropion SR) abstracts accepted for poster presentations and an oral presentation at the upcoming ObesityWeek meeting. This meeting will...

2013-11-11 16:23:05

GO Team: An Alliance of Grey and Ogilvy NEW YORK, Nov. 11, 2013 /PRNewswire/ -- WPP's GO Team, a joint alliance of Grey and Ogilvy, today announced that it has been selected by GlaxoSmithKline as global agency-of-record for antacid brands, Tums and Eno, after a review. The GO Team will be responsible for integrated consumer communications, including television, print and digital advertising. Anna Humiecka, Global Marketing Director, GI Health, GlaxoSmithKline, cited the quality...

2013-11-01 08:27:46

NEW YORK, Nov. 1, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), and GlaxoSmithKline plc (NYSE: GSK). Today's readers may access these reports free of charge - including full price targets, industry analysis and...

2013-10-30 23:34:03

MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: Asthma Therapeutics Market to 2019; http://www.marketresearch.com/land/product.asp?productid=7840710&progid=85830. Rockville, MD (PRWEB) October 30, 2013 Asthma Therapeutics Market to 2019 The asthma market is forecast to grow marginally to 2019 across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This...

2013-10-30 12:25:42

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease (COPD), is now available to pharmacies throughout the U.S. BREO ELLIPTA is a combination of the inhaled corticosteroid (ICS), fluticasone furoate "FF", and the long-acting beta(2)-agonist (LABA),...

2013-10-27 23:02:48

RnRMarketResearch.com adds latest report on “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Greece” to its store. Dallas, TX (PRWEB) October 27, 2013 The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Greece. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the...

2013-10-23 08:29:42

LONDON, October 23, 2013 /PRNewswire/ -- Global healthcare company GSK reported Q3 results showing group sales growth +1%, earnings per share +16% and strong cash generation which has enabled the company to re-affirm its guidance for the full year. In a video interview, CFO Simon Dingemans said the company was making good progress on reshaping and restructuring its cost base and that GSK was now seeing the benefit of savings in both in its operations and the transformed...

2013-10-21 08:25:51

DENVER, Oct. 21, 2013 /PRNewswire/ --MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, today announced that Sydney Rollock has joined the company as Chief Marketing Officer. In this role, Rollock will oversee global brand management, global marketing and sales, as well as help lead MusclePharm's corporate strategy to ultimately grow product lines and revenue streams. (Photo: http://photos.prnewswire.com/prnh/20130715/LA46954LOGO)...